Agoracom: Small Cap Investment - Resverlogix Corp. - Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

BearDownAZ

Jun 13, 2016 04:30PM

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

Jkj193741

Jun 13, 2016 04:59PM

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

BearDownAZ

Jun 13, 2016 05:10PM

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

Jkj193741

Jun 13, 2016 10:39PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

in response to

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.

Jkj193741

posted on Jun 13, 2016 11:46PM

RVX-297 was never tested in humans. The four expected 2016 publications were not restricted to RVX-208.

BearDownAZ

3 Recommendations

Re: New publication: RVX-297- a novel BD2 selective inhibitor of BET bromodomains.